Journal
SCIENCE ADVANCES
Volume 8, Issue 12, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.abl5723
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [32070917, 82030042, 91753141, 31800733]
- Shanghai Science and Technology Committee [20JC1417400, 201409005500, 20JC1410100]
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
- Shanghai Jiao Tong University School of Medicine
- Howard Hughes Medical Institute
Ask authors/readers for more resources
Colonic mucosal barrier dysfunction is a major cause of inflammatory bowel disease (IBD), and m(6)A modification plays a crucial role in maintaining the homeostatic self-renewal of colonic stem cells.
Colonic mucosal barrier dysfunction is one of the major causes of inflammatory bowel disease (IBD). However, the mechanisms underlying mucosal barrier dysfunction are poorly understood. N-6-methyladenosine (m(6)A) mRNA modification is an important modulator of epitranscriptional regulation of gene expression, participating in multiple physiological and pathological processes. However, the function of m(6)A modification in colonic epithelial cells and stem cells is unknown. Here, we show that m(6)A modification is essential for maintaining the homeostatic self-renewal in colonic stem cells. Specific deletion of the methyltransferase 14 (Mettl14) gene in mouse colon resulted in colonic stem cell apoptosis, causing mucosal barrier dysfunction and severe colitis. Mechanistically, we revealed that Mettl14 restricted colonic epithelial cell death by regulating the stability of Nfkbia mRNA and modulating the NF-kappa B pathway. Our results identified a previously unidentified role for m(6)A modification in colonic epithelial cells and stem cells, suggesting that m(6)A modification may be a potential therapeutic target for IBD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available